Global ADHD Medications Market Research Report 2023

Report ID: 2007127 | Published Date: Apr 2026 | No. of Page: 87 | Base Year: 2025 | Rating: 4.6
Request Sample Report
Pre-Order Enquiry 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global ADHD Medications Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Stimulant
        1.2.3 Non-stimulant
    1.3 Market by Application
        1.3.1 Global ADHD Medications Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Adult
        1.3.3 Children
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global ADHD Medications Market Perspective (2018-2029)
    2.2 ADHD Medications Growth Trends by Region
        2.2.1 Global ADHD Medications Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 ADHD Medications Historic Market Size by Region (2018-2023)
        2.2.3 ADHD Medications Forecasted Market Size by Region (2024-2029)
    2.3 ADHD Medications Market Dynamics
        2.3.1 ADHD Medications Industry Trends
        2.3.2 ADHD Medications Market Drivers
        2.3.3 ADHD Medications Market Challenges
        2.3.4 ADHD Medications Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top ADHD Medications Players by Revenue
        3.1.1 Global Top ADHD Medications Players by Revenue (2018-2023)
        3.1.2 Global ADHD Medications Revenue Market Share by Players (2018-2023)
    3.2 Global ADHD Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by ADHD Medications Revenue
    3.4 Global ADHD Medications Market Concentration Ratio
        3.4.1 Global ADHD Medications Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by ADHD Medications Revenue in 2022
    3.5 ADHD Medications Key Players Head office and Area Served
    3.6 Key Players ADHD Medications Product Solution and Service
    3.7 Date of Enter into ADHD Medications Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 ADHD Medications Breakdown Data by Type
    4.1 Global ADHD Medications Historic Market Size by Type (2018-2023)
    4.2 Global ADHD Medications Forecasted Market Size by Type (2024-2029)
5 ADHD Medications Breakdown Data by Application
    5.1 Global ADHD Medications Historic Market Size by Application (2018-2023)
    5.2 Global ADHD Medications Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America ADHD Medications Market Size (2018-2029)
    6.2 North America ADHD Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America ADHD Medications Market Size by Country (2018-2023)
    6.4 North America ADHD Medications Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe ADHD Medications Market Size (2018-2029)
    7.2 Europe ADHD Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe ADHD Medications Market Size by Country (2018-2023)
    7.4 Europe ADHD Medications Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific ADHD Medications Market Size (2018-2029)
    8.2 Asia-Pacific ADHD Medications Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific ADHD Medications Market Size by Region (2018-2023)
    8.4 Asia-Pacific ADHD Medications Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America ADHD Medications Market Size (2018-2029)
    9.2 Latin America ADHD Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America ADHD Medications Market Size by Country (2018-2023)
    9.4 Latin America ADHD Medications Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa ADHD Medications Market Size (2018-2029)
    10.2 Middle East & Africa ADHD Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa ADHD Medications Market Size by Country (2018-2023)
    10.4 Middle East & Africa ADHD Medications Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Amneal Pharmaceuticals
        11.1.1 Amneal Pharmaceuticals Company Detail
        11.1.2 Amneal Pharmaceuticals Business Overview
        11.1.3 Amneal Pharmaceuticals ADHD Medications Introduction
        11.1.4 Amneal Pharmaceuticals Revenue in ADHD Medications Business (2018-2023)
        11.1.5 Amneal Pharmaceuticals Recent Development
    11.2 Eli Lilly and Co.
        11.2.1 Eli Lilly and Co. Company Detail
        11.2.2 Eli Lilly and Co. Business Overview
        11.2.3 Eli Lilly and Co. ADHD Medications Introduction
        11.2.4 Eli Lilly and Co. Revenue in ADHD Medications Business (2018-2023)
        11.2.5 Eli Lilly and Co. Recent Development
    11.3 Johnson and Johnson Services
        11.3.1 Johnson and Johnson Services Company Detail
        11.3.2 Johnson and Johnson Services Business Overview
        11.3.3 Johnson and Johnson Services ADHD Medications Introduction
        11.3.4 Johnson and Johnson Services Revenue in ADHD Medications Business (2018-2023)
        11.3.5 Johnson and Johnson Services Recent Development
    11.4 NEOS Therapeutic
        11.4.1 NEOS Therapeutic Company Detail
        11.4.2 NEOS Therapeutic Business Overview
        11.4.3 NEOS Therapeutic ADHD Medications Introduction
        11.4.4 NEOS Therapeutic Revenue in ADHD Medications Business (2018-2023)
        11.4.5 NEOS Therapeutic Recent Development
    11.5 Takeda Pharmaceutical
        11.5.1 Takeda Pharmaceutical Company Detail
        11.5.2 Takeda Pharmaceutical Business Overview
        11.5.3 Takeda Pharmaceutical ADHD Medications Introduction
        11.5.4 Takeda Pharmaceutical Revenue in ADHD Medications Business (2018-2023)
        11.5.5 Takeda Pharmaceutical Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Detail
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer ADHD Medications Introduction
        11.6.4 Pfizer Revenue in ADHD Medications Business (2018-2023)
        11.6.5 Pfizer Recent Development
    11.7 Lupin
        11.7.1 Lupin Company Detail
        11.7.2 Lupin Business Overview
        11.7.3 Lupin ADHD Medications Introduction
        11.7.4 Lupin Revenue in ADHD Medications Business (2018-2023)
        11.7.5 Lupin Recent Development
    11.8 Shire
        11.8.1 Shire Company Detail
        11.8.2 Shire Business Overview
        11.8.3 Shire ADHD Medications Introduction
        11.8.4 Shire Revenue in ADHD Medications Business (2018-2023)
        11.8.5 Shire Recent Development
    11.9 Mallinckrodt
        11.9.1 Mallinckrodt Company Detail
        11.9.2 Mallinckrodt Business Overview
        11.9.3 Mallinckrodt ADHD Medications Introduction
        11.9.4 Mallinckrodt Revenue in ADHD Medications Business (2018-2023)
        11.9.5 Mallinckrodt Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global ADHD Medications Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Stimulant
    Table 3. Key Players of Non-stimulant
    Table 4. Global ADHD Medications Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global ADHD Medications Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global ADHD Medications Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global ADHD Medications Market Share by Region (2018-2023)
    Table 8. Global ADHD Medications Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global ADHD Medications Market Share by Region (2024-2029)
    Table 10. ADHD Medications Market Trends
    Table 11. ADHD Medications Market Drivers
    Table 12. ADHD Medications Market Challenges
    Table 13. ADHD Medications Market Restraints
    Table 14. Global ADHD Medications Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global ADHD Medications Market Share by Players (2018-2023)
    Table 16. Global Top ADHD Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Medications as of 2022)
    Table 17. Ranking of Global Top ADHD Medications Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by ADHD Medications Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players ADHD Medications Product Solution and Service
    Table 21. Date of Enter into ADHD Medications Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global ADHD Medications Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global ADHD Medications Revenue Market Share by Type (2018-2023)
    Table 25. Global ADHD Medications Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global ADHD Medications Revenue Market Share by Type (2024-2029)
    Table 27. Global ADHD Medications Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global ADHD Medications Revenue Market Share by Application (2018-2023)
    Table 29. Global ADHD Medications Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global ADHD Medications Revenue Market Share by Application (2024-2029)
    Table 31. North America ADHD Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America ADHD Medications Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America ADHD Medications Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe ADHD Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe ADHD Medications Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe ADHD Medications Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific ADHD Medications Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific ADHD Medications Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific ADHD Medications Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America ADHD Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America ADHD Medications Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America ADHD Medications Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa ADHD Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa ADHD Medications Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa ADHD Medications Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Amneal Pharmaceuticals Company Detail
    Table 47. Amneal Pharmaceuticals Business Overview
    Table 48. Amneal Pharmaceuticals ADHD Medications Product
    Table 49. Amneal Pharmaceuticals Revenue in ADHD Medications Business (2018-2023) & (US$ Million)
    Table 50. Amneal Pharmaceuticals Recent Development
    Table 51. Eli Lilly and Co. Company Detail
    Table 52. Eli Lilly and Co. Business Overview
    Table 53. Eli Lilly and Co. ADHD Medications Product
    Table 54. Eli Lilly and Co. Revenue in ADHD Medications Business (2018-2023) & (US$ Million)
    Table 55. Eli Lilly and Co. Recent Development
    Table 56. Johnson and Johnson Services Company Detail
    Table 57. Johnson and Johnson Services Business Overview
    Table 58. Johnson and Johnson Services ADHD Medications Product
    Table 59. Johnson and Johnson Services Revenue in ADHD Medications Business (2018-2023) & (US$ Million)
    Table 60. Johnson and Johnson Services Recent Development
    Table 61. NEOS Therapeutic Company Detail
    Table 62. NEOS Therapeutic Business Overview
    Table 63. NEOS Therapeutic ADHD Medications Product
    Table 64. NEOS Therapeutic Revenue in ADHD Medications Business (2018-2023) & (US$ Million)
    Table 65. NEOS Therapeutic Recent Development
    Table 66. Takeda Pharmaceutical Company Detail
    Table 67. Takeda Pharmaceutical Business Overview
    Table 68. Takeda Pharmaceutical ADHD Medications Product
    Table 69. Takeda Pharmaceutical Revenue in ADHD Medications Business (2018-2023) & (US$ Million)
    Table 70. Takeda Pharmaceutical Recent Development
    Table 71. Pfizer Company Detail
    Table 72. Pfizer Business Overview
    Table 73. Pfizer ADHD Medications Product
    Table 74. Pfizer Revenue in ADHD Medications Business (2018-2023) & (US$ Million)
    Table 75. Pfizer Recent Development
    Table 76. Lupin Company Detail
    Table 77. Lupin Business Overview
    Table 78. Lupin ADHD Medications Product
    Table 79. Lupin Revenue in ADHD Medications Business (2018-2023) & (US$ Million)
    Table 80. Lupin Recent Development
    Table 81. Shire Company Detail
    Table 82. Shire Business Overview
    Table 83. Shire ADHD Medications Product
    Table 84. Shire Revenue in ADHD Medications Business (2018-2023) & (US$ Million)
    Table 85. Shire Recent Development
    Table 86. Mallinckrodt Company Detail
    Table 87. Mallinckrodt Business Overview
    Table 88. Mallinckrodt ADHD Medications Product
    Table 89. Mallinckrodt Revenue in ADHD Medications Business (2018-2023) & (US$ Million)
    Table 90. Mallinckrodt Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global ADHD Medications Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global ADHD Medications Market Share by Type: 2022 VS 2029
    Figure 3. Stimulant Features
    Figure 4. Non-stimulant Features
    Figure 5. Global ADHD Medications Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global ADHD Medications Market Share by Application: 2022 VS 2029
    Figure 7. Adult Case Studies
    Figure 8. Children Case Studies
    Figure 9. ADHD Medications Report Years Considered
    Figure 10. Global ADHD Medications Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 11. Global ADHD Medications Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global ADHD Medications Market Share by Region: 2022 VS 2029
    Figure 13. Global ADHD Medications Market Share by Players in 2022
    Figure 14. Global Top ADHD Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Medications as of 2022)
    Figure 15. The Top 10 and 5 Players Market Share by ADHD Medications Revenue in 2022
    Figure 16. North America ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 17. North America ADHD Medications Market Share by Country (2018-2029)
    Figure 18. United States ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. Canada ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Europe ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe ADHD Medications Market Share by Country (2018-2029)
    Figure 22. Germany ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. France ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. U.K. ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Italy ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Russia ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Nordic Countries ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Asia-Pacific ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific ADHD Medications Market Share by Region (2018-2029)
    Figure 30. China ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Japan ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. South Korea ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Southeast Asia ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. India ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Australia ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Latin America ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America ADHD Medications Market Share by Country (2018-2029)
    Figure 38. Mexico ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Brazil ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Middle East & Africa ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa ADHD Medications Market Share by Country (2018-2029)
    Figure 42. Turkey ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Saudi Arabia ADHD Medications Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Amneal Pharmaceuticals Revenue Growth Rate in ADHD Medications Business (2018-2023)
    Figure 45. Eli Lilly and Co. Revenue Growth Rate in ADHD Medications Business (2018-2023)
    Figure 46. Johnson and Johnson Services Revenue Growth Rate in ADHD Medications Business (2018-2023)
    Figure 47. NEOS Therapeutic Revenue Growth Rate in ADHD Medications Business (2018-2023)
    Figure 48. Takeda Pharmaceutical Revenue Growth Rate in ADHD Medications Business (2018-2023)
    Figure 49. Pfizer Revenue Growth Rate in ADHD Medications Business (2018-2023)
    Figure 50. Lupin Revenue Growth Rate in ADHD Medications Business (2018-2023)
    Figure 51. Shire Revenue Growth Rate in ADHD Medications Business (2018-2023)
    Figure 52. Mallinckrodt Revenue Growth Rate in ADHD Medications Business (2018-2023)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amneal Pharmaceuticals
Eli Lilly and Co.
Johnson and Johnson Services
NEOS Therapeutic
Takeda Pharmaceutical
Pfizer
Lupin
Shire
Mallinckrodt
Frequently Asked Questions
ADHD Medications report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
ADHD Medications report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
ADHD Medications report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Portable Power Box

This report aims to provide a comprehensive presentation of the global market for Portable Power  ... Read More